Armata Pharmaceuticals, Inc. (ARMP) stock
ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.17+0.51 (+19.17%)
Close on Nov 18, 2026Market cap $117.87MP/E –Yield –
Armata Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2014 it was $409.00K, up 404.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $409.00K | +404.9% |
| FY2013 | Dec 31, 2013 | $81.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | $31.00K | – |
See a number that looks wrong?